Medicure Financials

MPH Stock  CAD 0.89  0.14  18.67%   
We were able to interpolate thirty-three available fundamentals for Medicure, which can be compared to its peers in the industry. The stock experiences a very speculative upward sentiment. Check odds of Medicure to be traded at C$1.1125 in 90 days. Key indicators impacting Medicure's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio2.092.2
Notably Down
Pretty Stable
  
Please note, the imprecision that can be found in Medicure's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medicure. Check Medicure's Beneish M Score to see the likelihood of Medicure's management manipulating its earnings.

Medicure Stock Summary

Medicure competes with Biosyent, Covalon Technologies, Cipher Pharmaceuticals, and Knight Therapeutics. Medicure Inc., a pharmaceutical company, engages in the development and commercialization of therapies for the cardiovascular market in the United States. The company was founded in 1997 and is headquartered in Winnipeg, Canada. MEDICURE INC operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange.
Foreign Associate
  UK
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentCanada Stock View All
ExchangeTSX Venture Exchange
ISINCA58469E4085
Business Address2-1250 Waverley Street,
SectorPharmaceuticals
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.medicure.com
Phone204 487 7412
CurrencyCAD - Canadian Dollar
You should never invest in Medicure without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Medicure Stock, because this is throwing your money away. Analyzing the key information contained in Medicure's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Medicure Key Financial Ratios

There are many critical financial ratios that Medicure's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Medicure reports annually and quarterly.

Medicure Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets34.1M28.4M29.9M28.1M32.3M39.2M
Net Debt(1.3M)(2.5M)(4.0M)(5.8M)(6.7M)(6.4M)
Retained Earnings(65.6M)(66.3M)(64.9M)(65.9M)(59.3M)(62.2M)
Cash2.7M3.7M4.9M6.4M5.7M6.8M
Net Receivables5.3M4.7M5.6M4.8M5.5M7.7M
Other Current Assets2.6M872K1.1M1.1M1.3M2.0M
Total Liab14.9M10.0M8.9M8.2M9.4M8.9M
Total Current Assets15.7M12.6M14.8M15.2M17.5M23.7M
Common Stock122.9M85.4M80.9M81.0M93.2M98.8M
Accounts Payable7.0M6.7M7.1M7.2M8.3M5.7M
Inventory5.1M3.3M3.2M2.9M3.3M2.4M
Intangible Assets13.6M11.2M10.6M8.9M10.3M10.5M
Other Assets12.2M39K156K57K65.6K62.3K
Short Term Debt367K380K346K315K283.5K269.3K
Other Current Liab2.3M716K179K382K343.8K326.6K
Other Liab3.2M2.8M1.5M696K626.4K595.1K
Net Tangible Assets81.9M17.3M2.6M4.2M4.9M7.8M
Net Invested Capital19.1M18.4M21.0M19.9M17.9M30.8M
Net Working Capital3.4M4.0M6.5M7.3M6.5M6.2M

Medicure Key Income Statement Accounts

202020212022202320242025 (projected)
Total Revenue11.6M21.7M23.1M21.7M24.9M26.2M
Gross Profit5.1M12.7M16.1M13.6M15.6M8.9M
Operating Income(7.3M)(574K)1.3M(854K)(982.1K)(1.0M)
Ebit(7.3M)(574K)1.3M(854K)(982.1K)(1.0M)
Research Development3.3M1.8M2.8M2.4M2.2M2.1M
Ebitda(4.5M)2.6M3.4M1.3M1.5M1.6M
Net Income(6.8M)(727K)1.4M(922K)(1.1M)(1.1M)
Income Before Tax(6.8M)(759K)1.4M(897K)(1.0M)(1.1M)
Income Tax Expense49K(32K)20K25K22.5K21.4K
Interest Expense49K38K23K20K18K17.1K
Cost Of Revenue6.5M9.0M7.0M8.1M9.4M9.8M
Tax Provision247K(32K)20K25K28.8K30.2K
Net Interest Income771K(347K)(206K)65K74.8K78.5K
Interest Income43K78K10K75K67.5K64.1K

Medicure Key Cash Accounts

202020212022202320242025 (projected)
Change In Cash(10.2M)978K1.2M1.5M1.4M1.4M
Free Cash Flow(2.2M)3.2M1.5M1.8M2.1M2.2M
Depreciation2.8M3.1M2.1M2.2M2.5M1.6M
Capital Expenditures2K818K310K270K310.5K295.0K
Net Income(6.8M)(727K)1.4M(922K)(1.1M)(1.1M)
End Period Cash Flow2.7M3.7M4.9M6.4M5.7M6.8M
Change To Inventory723K471K166K(31K)(27.9K)(29.3K)
Other Non Cash Items(1.1M)(20K)(1.3M)51K45.9K48.2K
Change To Netincome(6.2M)11.7M(873K)83K95.5K100.2K
Investments(7.2M)(2.7M)(310K)(270K)(310.5K)(326.0K)

Medicure Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Medicure's current stock value. Our valuation model uses many indicators to compare Medicure value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medicure competition to find correlations between indicators driving Medicure's intrinsic value. More Info.
Medicure is regarded fourth in return on equity category among its peers. It also is regarded fourth in return on asset category among its peers . At this time, Medicure's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medicure's earnings, one of the primary drivers of an investment's value.

Medicure Systematic Risk

Medicure's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Medicure volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Medicure correlated with the market. If Beta is less than 0 Medicure generally moves in the opposite direction as compared to the market. If Medicure Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Medicure is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Medicure is generally in the same direction as the market. If Beta > 1 Medicure moves generally in the same direction as, but more than the movement of the benchmark.

Medicure Total Assets Over Time

Today, most investors in Medicure Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Medicure's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Medicure growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.11

At this time, Medicure's Price Earnings To Growth Ratio is fairly stable compared to the past year.

Medicure March 18, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Medicure help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Medicure. We use our internally-developed statistical techniques to arrive at the intrinsic value of Medicure based on widely used predictive technical indicators. In general, we focus on analyzing Medicure Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Medicure's daily price indicators and compare them against related drivers.

Additional Tools for Medicure Stock Analysis

When running Medicure's price analysis, check to measure Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicure is operating at the current time. Most of Medicure's value examination focuses on studying past and present price action to predict the probability of Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicure's price. Additionally, you may evaluate how the addition of Medicure to your portfolios can decrease your overall portfolio volatility.